They identified patients with lymphoid leukemia that switched to myeloid leukemia ... a PhD candidate in the Termini Lab at Fred Hutch Cancer Center. She studies how acute myeloid leukemia cells ...

On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...

Introduction Blood cancer diagnostics refers to the process of detecting and identifying cancers that affect the blood, bone marrow, and lympha ...

Brookline Capital Markets initiated coverage on Marker Therapeutics (NASDAQ:MRKR), a company focused on developing T cell-based immunotherapies for cancer, with a Buy rating and a 12-to-18-month price ...

Zelenirstat, a cancer-fighting pill made in Alberta, may have the power to save lives — but millions more in clinical trial funding and donations are needed to make it a reality.

During a Case-Based Roundtable® event, Muhammad Umair Mushtaq, MD, discussed managing long-term toxicity concerns related to ...

SOPHiA GENETICS (NASDAQ:SOPH – Get Free Report) and Caribou Biosciences (NASDAQ:CRBU – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the ...

Incyte (NASDAQ:INCY – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a note issued to investors on Wednesday. A number ...

The first patient to die was the first patient to try the drug, a 78 year-old man with BPDCN, although the main phase 1 trial is testing the drug in acute myeloid lymphoma. Sourdive said the ...